ULTRAGENYX PHARMACEUTICAL INC. - COMMON STOCK
45.35
07-2月-25 15:45:00
15 分の遅延
株式
-0.43
-0.94%
本日の幅
45.02 - 46.15
ISIN
N/A
ソース
NASDAQ
-
03 1 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Ultragenyx to Present at the 42nd Annual J.P. Morgan Healthcare Conference
02 1 2024 15:05:00 提供 Nasdaq GlobeNewswire
-
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
21 12 2023 15:30:00 提供 Nasdaq GlobeNewswire
-
Ultragenyx to Participate at Investor Conferences in November
20 11 2023 15:30:00 提供 Nasdaq GlobeNewswire
-
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
17 11 2023 15:30:00 提供 Nasdaq GlobeNewswire
-
Ultragenyx to Participate in the Jefferies London Healthcare Conference
07 11 2023 16:00:00 提供 Nasdaq GlobeNewswire
-
Ultragenyx Reports Third Quarter 2023 Financial Results and Corporate Update
02 11 2023 15:05:01 提供 Nasdaq GlobeNewswire
-
Ultragenyx to Host Conference Call for Third Quarter 2023 Financial Results and Corporate Update
26 10 2023 15:05:00 提供 Nasdaq GlobeNewswire
-
23 10 2023 15:01:00 提供 Nasdaq GlobeNewswire
-
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
20 10 2023 15:00:00 提供 Nasdaq GlobeNewswire
-
Ultragenyx Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
18 10 2023 20:16:45 提供 Nasdaq GlobeNewswire
-
Ultragenyx Announces Proposed Public Offering of Common Stock
17 10 2023 15:02:14 提供 Nasdaq GlobeNewswire
-
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
12 10 2023 16:00:00 提供 Nasdaq GlobeNewswire
-
09 10 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
Ultragenyx to Present Pipeline Update at Analyst Day on Monday, October 16, 2023
05 10 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
20 9 2023 16:00:00 提供 Nasdaq GlobeNewswire